{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:32Z","timestamp":1786988132782,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018739","name":"Faculty of Science, Medicine and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004477","name":"Universiteit Stellenbosch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejphar.2021.174612","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T20:52:45Z","timestamp":1635799965000},"page":"174612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K\/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells"],"prefix":"10.1016","volume":"912","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-7890","authenticated-orcid":false,"given":"Mogammad Baaghith","family":"Hamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Mendes","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-3566","authenticated-orcid":false,"given":"John Mbabuni","family":"Akudugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174612_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/13543776.2012.644274","article-title":"Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review","volume":"22","author":"Bajwa","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2021.174612_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2021.174612_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4161\/cbt.7.5.5712","article-title":"Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination","volume":"7","author":"Berglind","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2021.174612_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1306619","article-title":"Cellular immunotherapies for cancer","volume":"6","author":"Berraondo","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejphar.2021.174612_bib5","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2021.174612_bib6","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174612_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00280-012-2043-3","article-title":"Overcoming acquired resistance to anticancer therapy: focus on the PI3K\/AKT\/mTOR pathway","volume":"71","author":"Burris","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174612_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1087057109357788","article-title":"BacMam-enabled LanthaScreen cellular assays for PI3K\/Akt pathway compound profiling in disease-relevant cell backgrounds","volume":"15","author":"Carlson","year":"2010","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejphar.2021.174612_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1947601911408079","article-title":"RAS interaction with PI3K: more than just another effector pathway","volume":"3","author":"Castellano","year":"2011","journal-title":"Genes Canc."},{"key":"10.1016\/j.ejphar.2021.174612_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/157436206775269181","article-title":"Design and development of signal transduction inhibitors for cancer treatment: experience and challenges with kinase targets","volume":"1","author":"Collins","year":"2006","journal-title":"Curr. Signal Transduct. Ther."},{"key":"10.1016\/j.ejphar.2021.174612_bib11","first-page":"222","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2021.174612_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2217\/fon.15.53","article-title":"Human papillomavirus confers radiosensitivity in cancer cervix: a hypothesis toward a possible restoration of apoptotic pathways based on clinical outcomes","volume":"9","author":"Datta","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejphar.2021.174612_bib13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of cancer pharmacological treatments at the turn of the third millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174612_bib14","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1038\/s41598-017-02831-9","article-title":"Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway","volume":"1","author":"Fischer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174612_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tiv.2016.10.002","article-title":"Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells","volume":"38","author":"Hamunyela","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2021.174612_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18314\/gjct.v1i1.33","article-title":"A cocktail of specific inhibitors of HER-2, PI3K, and mTOR radiosensitises human breast cancer cells","volume":"1","author":"Hamunyela","year":"2015","journal-title":"J. Cancer Biol. Therap."},{"key":"10.1016\/j.ejphar.2021.174612_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ccell.2015.04.010","article-title":"Small-molecule Bcl-2 BH4 antagonist for lung cancer therapy","volume":"27","author":"Han","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2021.174612_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.mce.2013.03.014","article-title":"STAT signaling in mammary gland differentiation, cell survival and tumorigenesis","volume":"382","author":"Haricharan","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.174612_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ctrv.2012.04.008","article-title":"Current approaches and future directions in the treatment of HER2-positive breast cancer","volume":"9","author":"Hurvitz","year":"2013","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejphar.2021.174612_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4161\/cbt.7.4.5533","article-title":"Differential sensitivity of A549 non-small lung carcinoma cell responses to epidermal growth factor receptor pathway inhibitors","volume":"7","author":"Jaramillo","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2021.174612_bib21","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.yexcr.2006.05.008","article-title":"Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting","volume":"312","author":"Jaramillo","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2021.174612_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1158\/1535-7163.1365.3.11","article-title":"Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity","volume":"3","author":"Kasibhatla","year":"2004","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2021.174612_bib23","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.359.6382.1344","article-title":"The cancer immunotherapy revolution","volume":"359","author":"Kelly","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174612_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1748-717X-7-39","article-title":"DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity","volume":"7","author":"Kim","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ejphar.2021.174612_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02982830","article-title":"The mechanism of the induction by radiation of chromosome aberrations in tradescantia","volume":"44","author":"Lea","year":"1942","journal-title":"J. Genet."},{"key":"10.1016\/j.ejphar.2021.174612_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ijo.2020.5088","article-title":"Cutaneous melanoma and the immunotherapy revolution (Review)","volume":"57","author":"Leonardi","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.174612_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bjc.2011.222","article-title":"EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target","volume":"105","author":"Lida","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2021.174612_bib28","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2021.174612_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0027-5107(97)00150-4","article-title":"Modulation of NF-\u03baB, p53 and Bcl-2 in apoptosis induced by cisplatin in HeLa cells","volume":"381","author":"Maldonado","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejphar.2021.174612_bib30","first-page":"37","article-title":"PI3K and mTOR inhibitor, NVP-BEZ235, is more toxic than X-rays in prostate cancer cells","volume":"17","author":"Maleka","year":"2019","journal-title":"Int. J. Radiat. Res."},{"key":"10.1016\/j.ejphar.2021.174612_bib31","doi-asserted-by":"crossref","first-page":"453497","DOI":"10.1155\/2014\/453497","article-title":"Effects of single or combined treatments with radiation and chemotherapy on survival and danger signals in glioblastoma cell lines","volume":"2014","author":"Pasi","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2021.174612_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM199309023291003","article-title":"Bcl-2 protein in non-small-cell lung carcinoma","volume":"329","author":"Pezzella","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174612_bib33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-2952(02)01296-0","article-title":"The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle","volume":"4","author":"Pozo-Guisado","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174612_bib34","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1038\/onc.2014.314","article-title":"Mechanism-based cancer therapy: resistance to therapy, therapy for resistance","volume":"34","author":"Ramos","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174612_bib35","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41598-018-38004-5","article-title":"Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities","volume":"9","author":"Riaz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174612_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molmed.2015.11.005","article-title":"Small molecule modulators of pre-mRNA splicing in cancer therapy","volume":"22","author":"Salton","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174612_bib37","first-page":"67","article-title":"Radiosensitivity and repair kinetics of gamma irradiated leukocytes from sporadic prostate cancer patients and healthy individuals assessed by alkaline comet assay","volume":"14","author":"Shahidi","year":"2010","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.ejphar.2021.174612_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/ol.2013.1707","article-title":"Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro","volume":"7","author":"Song","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2021.174612_bib39","first-page":"35","article-title":"The expression patterns of ER, PR, HER2, CK5\/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines","volume":"4","author":"Subik","year":"2010","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejphar.2021.174612_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.taap.2014.01.012","article-title":"Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy","volume":"275","author":"Sundarraj","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174612_bib41","first-page":"1387","article-title":"Natural products as inducers of apoptosis: implication for cancer therapy and prevention","volume":"80","author":"Taraphdar","year":"2001","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejphar.2021.174612_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10915810490265432","article-title":"The involvement of p53 in paraquat-induced apoptosis in human lung epithelial-like cells","volume":"23","author":"Takeyama","year":"2014","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174612_bib43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/1541-7786.MCR-06-0297","article-title":"Stimulated PI3K-Akt signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity","volume":"5","author":"Toulany","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejphar.2021.174612_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1520-6823(1998)6:3<109::AID-ROI1>3.0.CO;2-1","article-title":"Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines","volume":"6","author":"Verheye-Dua","year":"1998","journal-title":"Radiat. Oncol. Invest."},{"key":"10.1016\/j.ejphar.2021.174612_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1471-2407-10-441","article-title":"In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells","volume":"10","author":"Wouters","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2021.174612_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers11040471","article-title":"Upregulation of complement factor H by SOCS-1\/3-STAT4 in lung cancer","volume":"11","author":"Yoon","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2021.174612_bib47","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.analchem.5b02572","article-title":"Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging","volume":"87","author":"Zhang","year":"2015","journal-title":"Anal. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:15:17Z","timestamp":1762143317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921007688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"alternative-id":["S0014299921007688"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174612","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K\/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174612"}}